8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Jan 11, 2010)

Filed January 11, 2010For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on January 11, 2010, to disclose information relevant to upcoming discussions with securities analysts and investors. The primary purpose of this filing was to reaffirm the company's earnings per share (EPS) guidance for the full year 2009. This reaffirmation suggests that management was confident in their ability to meet previously stated financial expectations for the year. While the filing itself does not contain new financial results or significant business updates, it serves as a regulatory disclosure mechanism to ensure transparency when company officers are engaging with the investment community. The report also includes a standard 'Safe Harbor' statement, highlighting the forward-looking nature of certain discussions and the inherent risks and uncertainties associated with such projections. Investors should note that the information provided is supplementary and intended to align with previously communicated guidance.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) reaffirmed its full-year 2009 earnings per share (EPS) guidance.
  • 2The reaffirmation was communicated in preparation for meetings with securities analysts and investors on January 11, 2010.
  • 3This 8-K filing serves as a Regulation FD disclosure.
  • 4The company's officers expect to reiterate previously provided financial guidance.
  • 5A comprehensive 'Safe Harbor' statement is included, outlining risks and uncertainties related to forward-looking statements.
  • 6No new financial results or material business changes were announced in this filing.

Frequently Asked Questions